Publication|Articles|May 16, 2025
- Pharmaceutical Executive: May 2025
- Volume 45
- Issue 4
Pharmaceutical Executive: May 2025 Interactive Digital Edition
View the Pharmaceutical Executive May 2025 issue in an interactive format.
Advertisement
Articles in this issue
about 1 year ago
Your Voice Boxabout 1 year ago
Pharm Exec's 2025 State of the Industry Surveyabout 1 year ago
Reshema Kemps-Polanco: Taking Risks for Greater Rewardabout 1 year ago
Earned Media and ASCO: Provide Context Beyond the Dataabout 1 year ago
How Does the Shift to Early-Stage M&A Change Due Diligence?about 1 year ago
The Three Pillars of Pharma’s New Commercial Modelabout 1 year ago
Revenue Optimization: The Money Matters—That Matter Mostabout 1 year ago
Bridging the Gap: A Large Pharma BlueprintAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5